<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35843530</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9327</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Molecular and cellular neurosciences</Title><ISOAbbreviation>Mol Cell Neurosci</ISOAbbreviation></Journal><ArticleTitle>Hyperactivity of Purkinje cell and motor deficits in C9orf72 knockout mice.</ArticleTitle><Pagination><StartPage>103756</StartPage><MedlinePgn>103756</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mcn.2022.103756</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1044-7431(22)00062-8</ELocationID><Abstract><AbstractText>A hexanucleotide (GGGGCC) repeat expansion in the first intron of the C9ORF72 gene is the most frequently reported genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The cerebellum has not traditionally been thought to be involved in the pathogenesis of C9ORF72-associated ALS/FTD, but recent evidence suggested a potential role. C9ORF72 is highly expressed in the cerebellum. Decreased C9ORF72 transcript and protein levels were detected in the postmortem cerebellum, suggesting a loss-of-function effect of C9ORF72 mutation. This study investigated the role of loss of C9ORF72 function using a C9orf72 knockout mouse line. C9orf72 deficiency led to motor impairment in rotarod, beam-walking, paw-print, open-field, and grip-strength tests. Purkinje cells are the sole output neurons in the cerebellum, and we next determined their involvement in the motor phenotypes. We found hyperactivity of Purkinje cells in the C9orf72 knockout mouse accompanied by a significant increase of the large-conductance calcium-activated potassium channel (BK) protein in the cerebellum. The link between BK and Purkinje cell firing was demonstrated by the acute application of the BK activator that increased the firing frequency of the Purkinje cells ex vivo. In vivo chemogenetic activation of Purkinje cells in wild-type mice led to similar motor deficits in rotarod and beam-walking tests. Our results highlight that C9ORF72 loss alters the activity of the Purkinje cell and potentially the pathogenesis of the disease. Manipulating the Purkinje cell firing or cerebellar output may contribute to C9ORF72-associated ALS/FTD treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuning</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, United States; Genetics Institute, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ernst</LastName><ForeName>Alexis F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Canna</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maugee</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, United States; Genetics Institute, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoi</LastName><ForeName>Fumiaki</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakshmana</LastName><ForeName>Madepalli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology and Nano-Medicine, The Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Norman Fixel Institute for Neurological Diseases, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, United States. Electronic address: yuqingli@ufl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS082244</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS111498</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS118397</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell Neurosci</MedlineTA><NlmUniqueID>9100095</NlmUniqueID><ISSNLinking>1044-7431</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606498">C9orf72 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011689" MajorTopicYN="N">Purkinje Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BK channel</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Hyperactivity</Keyword><Keyword MajorTopicYN="N">Motor behavior</Keyword><Keyword MajorTopicYN="N">Purkinje cell</Keyword></KeywordList><CoiStatement><b>Declarations of interest:</b> None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>17</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35843530</ArticleId><ArticleId IdType="mid">NIHMS1916302</ArticleId><ArticleId IdType="pmc">PMC10369482</ArticleId><ArticleId IdType="doi">10.1016/j.mcn.2022.103756</ArticleId><ArticleId IdType="pii">S1044-7431(22)00062-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmed R, Irish M, Piguet O, Halliday G, Ittner L, Farooqi S, &#x2026; Kiernan M (2016). Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. The Lancet. Neurology, 15(3). 10.1016/S1474-4422(15)00380-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00380-4</ArticleId><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Amende I, Kale A, McCue S, Glazier S, Morgan J, &amp; Hampton T (2005). Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. Journal of neuroengineering and rehabilitation, 2. 10.1186/1743-0003-2-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-0003-2-20</ArticleId><ArticleId IdType="pmc">PMC1201165</ArticleId><ArticleId IdType="pubmed">16042805</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, &#x2026; Oda T (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun, 351(3), 602&#x2013;611. 10.1016/j.bbrc.2006.10.093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, &#x2026; Petrucelli L (2013). Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron, 77(4), 639&#x2013;646. 10.1016/j.neuron.2013.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A, Decman V, White D, Ramos M, Ikiz B, Lee HC, &#x2026; Lai KM (2016). C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep, 6, 23204. 10.1038/srep23204</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, &#x2026; Mann DM (2015). Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathol Appl Neurobiol, 41(5), 601&#x2013;612. 10.1111/nan.12178</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12178</ArticleId><ArticleId IdType="pmc">PMC4934135</ArticleId><ArticleId IdType="pubmed">25185840</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, &amp; Isaacs AM (2018). C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol, 14(9), 544&#x2013;558. 10.1038/s41582-018-0047-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, &#x2026; Petrucelli L (2013). Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol, 126(6), 895&#x2013;905. 10.1007/s00401-013-1199-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M, Cardoso MJ, Cash DM, Ourselin S, Warren JD, &amp; Rohrer JD (2016). Patterns of regional cerebellar atrophy in genetic frontotemporal dementia. Neuroimage Clin, 11, 287&#x2013;290. 10.1016/j.nicl.2016.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.02.008</ArticleId><ArticleId IdType="pmc">PMC4781923</ArticleId><ArticleId IdType="pubmed">26977398</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport J, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, &amp; Couratier P (2009). Hypermetabolism in ALS patients: an early and persistent phenomenon. Journal of neurology, 256(8). 10.1007/s00415-009-5100-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Braems E, Swinnen B, &amp; Van Den Bosch L (2020). C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta neuropathologica, 140(5). 10.1007/s00401-020-02214-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02214-x</ArticleId><ArticleId IdType="pmc">PMC7547039</ArticleId><ArticleId IdType="pubmed">32876811</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Suzuki N, Wang J, Moccia R, Mordes D, Stewart M, &#x2026; Eggan K (2016). Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Science translational medicine, 8(347). 10.1126/scitranslmed.aaf6038</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z, Pan Y, Giacomotto J, &amp; Patten S (2021). Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish. Communications biology, 4(1). 10.1038/s42003-021-02302-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02302-y</ArticleId><ArticleId IdType="pmc">PMC8233344</ArticleId><ArticleId IdType="pubmed">34172817</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, &#x2026; Morton AJ (1999). Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci, 19(8), 3248&#x2013;3257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782264</ArticleId><ArticleId IdType="pubmed">10191337</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter RJ, Morton J, &amp; Dunnett SB (2001). Motor coordination and balance in rodents. Curr Protoc Neurosci, Chapter 8, Unit 8.12. 10.1002/0471142301.ns0812s15</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142301.ns0812s15</ArticleId><ArticleId IdType="pubmed">18428540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cash DM, Bocchetta M, Thomas DL, Dick KM, van Swieten JC, Borroni B, &#x2026; Rohrer JD (2018). Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study. Neurobiol Aging, 62, 191&#x2013;196. 10.1016/j.neurobiolaging.2017.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.10.008</ArticleId><ArticleId IdType="pmc">PMC5759893</ArticleId><ArticleId IdType="pubmed">29172163</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelnovo V, Caminiti SP, Riva N, Magnani G, Silani V, &amp; Perani D (2019). Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation. Neurol Sci, 40(3), 515&#x2013;521. 10.1007/s10072-018-3685-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3685-7</ArticleId><ArticleId IdType="pubmed">30554355</ArticleId></ArticleIdList></Reference><Reference><Citation>Caston J, Jones N, &amp; Stelz T (1995). Role of preoperative and postoperative sensorimotor training on restoration of the equilibrium behavior in adult mice following cerebellectomy. Neurobiol Learn Mem, 64(3), 195&#x2013;202. 10.1006/nlme.1995.0002</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nlme.1995.0002</ArticleId><ArticleId IdType="pubmed">8564373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao O, Zhang H, Pathak S, Huston J, &amp; Yang Y (2021). Functional Convergence of Motor and Social Processes in Lobule IV/V of the Mouse Cerebellum. Cerebellum (London, England). 10.1007/s12311-021-01246-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-021-01246-7</ArticleId><ArticleId IdType="pmc">PMC8417139</ArticleId><ArticleId IdType="pubmed">33661502</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, &#x2026; Chio A (2014). The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging, 41(5), 844&#x2013;852. 10.1007/s00259-013-2667-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-013-2667-5</ArticleId><ArticleId IdType="pmc">PMC8957062</ArticleId><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Higginbottom A, Stopford MJ, Highley JR, Ince PG, Wharton SB, &#x2026; Shaw PJ (2015). Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy. Acta Neuropathol, 130(1), 63&#x2013;75. 10.1007/s00401-015-1429-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1429-9</ArticleId><ArticleId IdType="pmc">PMC4468790</ArticleId><ArticleId IdType="pubmed">25943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Vourc'h P, Guennoc AM, Del Mar Amador M, Blasco H, Andres C, &#x2026; Meininger V (2016). Pure cerebellar ataxia linked to large C9orf72 repeat expansion. Amyotroph Lateral Scler Frontotemporal Degener, 17(3-4), 301&#x2013;303. 10.3109/21678421.2015.1113298</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1113298</ArticleId><ArticleId IdType="pubmed">26609732</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang MT, Yokoi F, McNaught KS, Jengelley TA, Jackson T, Li J, &amp; Li Y (2005). Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp Neurol, 196(2), 452&#x2013;463. 10.1016/j.expneurol.2005.08.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.08.025</ArticleId><ArticleId IdType="pubmed">16242683</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Finch NA, Wang X, Gendron TF, Bieniek KF, Heckman MG, &#x2026; Rademakers R (2017). In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers. Acta Neuropathol, 134(2), 255&#x2013;269. 10.1007/s00401-017-1725-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1725-7</ArticleId><ArticleId IdType="pmc">PMC5508036</ArticleId><ArticleId IdType="pubmed">28508101</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, &#x2026; Rademakers R (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72(2), 245&#x2013;256. 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, &#x2026; Rothstein JD (2013). RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron, 80(2), 415&#x2013;428. 10.1016/j.neuron.2013.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbert MTW, Ross CA, Pregent LJ, Lank RJ, Zhang C, Katzman RB, &#x2026; Belzil VV (2017). Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72-associated and sporadic ALS, and implicates SERPINA1 in disease. Acta Neuropathol, 134(5), 715&#x2013;728. 10.1007/s00401-017-1760-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1760-4</ArticleId><ArticleId IdType="pmc">PMC5647251</ArticleId><ArticleId IdType="pubmed">28808785</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgerton JR, &amp; Reinhart PH (2003). Distinct contributions of small and large conductance Ca2+-activated K+ channels to rat Purkinje neuron function. J Physiol, 548(Pt 1), 53&#x2013;69. 10.1113/jphysiol.2002.027854</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2002.027854</ArticleId><ArticleId IdType="pmc">PMC2342800</ArticleId><ArticleId IdType="pubmed">12576503</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P, &#x2026; Tison F (2002). Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience, 114(4), 1005&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pubmed">12379255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomin V, Richard P, Hoque M, Li C, Gu Z, Fissore-O'Leary M, &#x2026; Manley J (2018). The C9ORF72 Gene, Implicated in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, Encodes a Protein That Functions in Control of Endothelin and Glutamate Signaling. Molecular and cellular biology, 38(22). 10.1128/MCB.00155-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00155-18</ArticleId><ArticleId IdType="pmc">PMC6206455</ArticleId><ArticleId IdType="pubmed">30150298</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B, &amp; Taylor J (2017). The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD. Frontiers in molecular neuroscience, 10. 10.3389/fnmol.2017.00035</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fremont R, Tewari A, Angueyra C, &amp; Khodakhah K (2017). A role for cerebellum in the hereditary dystonia DYT1. Elife, 6. 10.7554/eLife.22775</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.22775</ArticleId><ArticleId IdType="pmc">PMC5340526</ArticleId><ArticleId IdType="pubmed">28198698</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P, Sellier C, Mackenzie IRA, Cheng CY, Tahraoui-Bories J, Martinat C, &#x2026; Neumann M (2018). Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun, 6(1), 72. 10.1186/s40478-018-0579-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, &#x2026; Petrucelli L (2013). Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol, 126(6), 829&#x2013;844. 10.1007/s00401-013-1192-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, van Blitterswijk M, Bieniek KF, Daughrity LM, Jiang J, Rush BK, &#x2026; Boylan KB (2015). Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathol, 130(4), 559&#x2013;573. 10.1007/s00401-015-1474-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1474-4</ArticleId><ArticleId IdType="pmc">PMC4575385</ArticleId><ArticleId IdType="pubmed">26350237</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, &#x2026; Van Broeckhoven C (2012). A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol, 11(1), 54&#x2013;65. 10.1016/S1474-4422(11)70261-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, He Q, Wan V, Adelman JP, Ohtsuki G, &amp; Hansel C (2016). Activity-Dependent Plasticity of Spike Pauses in Cerebellar Purkinje Cells. Cell Rep, 14(11), 2546&#x2013;2553. 10.1016/j.celrep.2016.02.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.02.054</ArticleId><ArticleId IdType="pmc">PMC4805497</ArticleId><ArticleId IdType="pubmed">26972012</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z, Liu L, Tao Z, Wang R, Ren H, Sun H, &#x2026; Wang G (2019). Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat Commun, 10(1), 2906. 10.1038/s41467-019-10956-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10956-w</ArticleId><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, &#x2026; van den Berg LH (2017). Amyotrophic lateral sclerosis. Nat Rev Dis Primers, 3, 17071. 10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausdorff J, Lertratanakul A, Cudkowicz M, Peterson A, Kaliton D, &amp; Goldberger A (2000). Dynamic markers of altered gait rhythm in amyotrophic lateral sclerosis. Journal of applied physiology (Bethesda, Md. : 1985), 88(6). 10.1152/jappl.2000.88.6.2045</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.2000.88.6.2045</ArticleId><ArticleId IdType="pubmed">10846017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornberger M. (2012). Assessment of psychiatric changes in C9ORF72 frontotemporal dementia. Alzheimers Res Ther, 4(6), 49. 10.1186/alzrt152</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt152</ArticleId><ArticleId IdType="pmc">PMC3580458</ArticleId><ArticleId IdType="pubmed">23269019</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshi E, Tremblay L, Feger J, Carras PL, &amp; Strick PL (2005). The cerebellum communicates with the basal ganglia. Nat Neurosci, 8(11), 1491&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pubmed">16205719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe N, Mori F, &amp; Shoumura K (2000). A di-synaptic projection from the lateral cerebellar nucleus to the laterodorsal part of the striatum via the central lateral nucleus of the thalamus in the rat. Brain Res, 880(1-2), 191&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">11033006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilg W, Golla H, Thier P, &amp; Giese M (2007). Specific influences of cerebellar dysfunctions on gait. Brain : a journal of neurology, 130(Pt 3). 10.1093/brain/awl376</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl376</ArticleId><ArticleId IdType="pubmed">17287287</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, &#x2026; Grossman M (2013). Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry, 84(2), 163&#x2013;169. 10.1136/jnnp-2012-303507</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303507</ArticleId><ArticleId IdType="pmc">PMC3543474</ArticleId><ArticleId IdType="pubmed">23117491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito M. (2008). Control of mental activities by internal models in the cerebellum. Nat Rev Neurosci, 9(4), 304&#x2013;313. 10.1038/nrn2332</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2332</ArticleId><ArticleId IdType="pubmed">18319727</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, &#x2026; Lagier-Tourenne C (2016). Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron, 90(3), 535&#x2013;550. 10.1016/j.neuron.2016.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaliszewska A, Allison J, Col T, Shaw C, &amp; Arias N (2021). Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD - a Systematic Review and Meta-Analysis. Cerebellum (London, England). 10.1007/s12311-021-01320-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-021-01320-0</ArticleId><ArticleId IdType="pmc">PMC9325807</ArticleId><ArticleId IdType="pubmed">34491551</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, Blokhuis A, Westeneng H, Terpstra M, Zundel C, Vieira de S&#xe1; R, &#x2026; Pasterkamp R (2015). C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Annals of neurology, 78(3). 10.1002/ana.24453</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, &#x2026; Ravits J (2013). Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A, 110(47), E4530&#x2013;4539. 10.1073/pnas.1318835110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshmana M, Chung J, Wickramarachchi S, Tak E, Bianchi E, Koo E, &amp; Kang D (2010). A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid-beta peptide generation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 24(1). 10.1096/fj.09-136457</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-136457</ArticleId><ArticleId IdType="pmc">PMC2797034</ArticleId><ArticleId IdType="pubmed">19729516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalonde R, Bensoula AN, &amp; Filali M (1995). Rotorod sensorimotor learning in cerebellar mutant mice. - PubMed - NCBI. Neurosci Res, 22(4), 423&#x2013;426. 10.1016/0168-0102(95)00916-h</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-0102(95)00916-h</ArticleId><ArticleId IdType="pubmed">7478307</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, &#x2026; Ranum LP (2016). C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron, 90(3), 521&#x2013;534. 10.1016/j.neuron.2016.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Xing H, Sheng W, Singh K, Korkmaz A, Comeau C, &#x2026; Li Y (2021). Alteration of the cholinergic system and motor deficits in cholinergic neuron-specific Dyt1 knockout mice. Neurobiology of disease. 10.1016/j.nbd.2021.105342</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105342</ArticleId><ArticleId IdType="pmc">PMC8113083</ArticleId><ArticleId IdType="pubmed">33757902</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Xing H, Wilkes B, Yokoi F, Chen H, Vaillancourt D, &amp; Li Y (2020). The abnormal firing of Purkinje cells in the knockin mouse model of DYT1 dystonia. Brain research bulletin, 165. 10.1016/j.brainresbull.2020.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.09.011</ArticleId><ArticleId IdType="pmc">PMC7674218</ArticleId><ArticleId IdType="pubmed">32976982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu S, Xing H, DeAndrade MP, Liu Y, Perez PD, Yokoi F, &#x2026; Li Y (2019). The role of BTBD9 in striatum and restless legs syndrome. eNeuro, 0277&#x2013;0219. 10.1523/eneuro.0277-19.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/eneuro.0277-19.2019</ArticleId><ArticleId IdType="pmc">PMC6787346</ArticleId><ArticleId IdType="pubmed">31444227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu S, Xing H, DeAndrade MP, Perez PD, Yokoi F, Febo M, &#x2026; Li Y (2020). The Role of BTBD9 in the Cerebellum, Sleep-like Behaviors and the Restless Legs Syndrome. Neuroscience, 440, 85&#x2013;96. 10.1016/j.neuroscience.2020.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.05.021</ArticleId><ArticleId IdType="pmc">PMC7363566</ArticleId><ArticleId IdType="pubmed">32446853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P, Grasser FA, Gendron TF, Petrucelli L, Cashman NR, &#x2026; Neumann M (2015). Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol, 130(6), 845&#x2013;861. 10.1007/s00401-015-1476-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1476-2</ArticleId><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLaren DA, Browne RW, Shaw JK, Krishnan Radhakrishnan S, Khare P, Espana RA, &amp; Clark SD (2016). Clozapine N-Oxide Administration Produces Behavioral Effects in Long-Evans Rats: Implications for Designing DREADD Experiments. eNeuro, 3(5). 10.1523/eneuro.0219-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/eneuro.0219-16.2016</ArticleId><ArticleId IdType="pmc">PMC5089539</ArticleId><ArticleId IdType="pubmed">27822508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney CJ, Downey LE, Ridgway GR, Beck J, Clegg S, Blair M, &#x2026; Warren JD (2012). Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimers Res Ther, 4(5), 41. 10.1186/alzrt144</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt144</ArticleId><ArticleId IdType="pmc">PMC3580398</ArticleId><ArticleId IdType="pubmed">23006986</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, &#x2026; Traynor BJ (2012). Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol, 11(4), 323&#x2013;330. 10.1016/s1474-4422(12)70043-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann DM, Rollinson S, Robinson A, Bennion Callister J, Thompson JC, Snowden JS, &#x2026; Pickering-Brown S (2013). Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol Commun, 1, 68. 10.1186/2051-5960-1-68</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-68</ArticleId><ArticleId IdType="pmc">PMC3893586</ArticleId><ArticleId IdType="pubmed">24252525</ArticleId></ArticleIdList></Reference><Reference><Citation>Meloni M, Farris R, Solla P, Mascia MM, Marrosu F, &amp; Cannas A (2017). C9ORF72 Intermediate Repeat Expansion in a Patient With Psychiatric Disorders and Progressive Cerebellar Ataxia. Neurologist, 22(6), 245&#x2013;246. 10.1097/nrl.0000000000000147</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nrl.0000000000000147</ArticleId><ArticleId IdType="pubmed">29095328</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Fratta P, &amp; Isaacs AM (2013). C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol, 126(6), 845&#x2013;857. 10.1007/s00401-013-1200-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1200-z</ArticleId><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordes D, Morrison B, Ament X, Cantrell C, Mok J, Eggan P, &#x2026; Rothstein J (2020). Absence of Survival and Motor Deficits in 500 Repeat C9ORF72 BAC Mice. Neuron, 108(4). 10.1016/j.neuron.2020.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.009</ArticleId><ArticleId IdType="pubmed">33022228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, &#x2026; Edbauer D (2013). The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science, 339(6125), 1335&#x2013;1338. 10.1126/science.1232927</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu D, Kwong L, Truax A, Micsenyi M, Chou T, &#x2026; Lee V (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, N.Y.), 314(5796). 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguon K, Ladd B, Baxter MG, &amp; Sajdel-Sulkowska EM (2005). Sexual dimorphism in cerebellar structure, function, and response to environmental perturbations. Prog Brain Res, 148, 341&#x2013;351. 10.1016/s0079-6123(04)48027-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0079-6123(04)48027-3</ArticleId><ArticleId IdType="pubmed">15661202</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, Bogdanik L, Yanez A, Lall D, Wolf AJ, Muhammad AK, &#x2026; Baloh RH (2016). C9orf72 is required for proper macrophage and microglial function in mice. Science, 351(6279), 1324&#x2013;1329. 10.1126/science.aaf1064</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtsuki G, &amp; Hansel C (2018). Synaptic Potential and Plasticity of an SK2 Channel Gate Regulate Spike Burst Activity in Cerebellar Purkinje Cells. iScience, 1, 49&#x2013;54. 10.1016/j.isci.2018.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2018.02.001</ArticleId><ArticleId IdType="pmc">PMC5993052</ArticleId><ArticleId IdType="pubmed">29888747</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney NT, Spina S, &amp; Miller BL (2017). Frontotemporal Dementia. Neurol Clin, 35(2), 339&#x2013;374. 10.1016/j.ncl.2017.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5472209</ArticleId><ArticleId IdType="pubmed">28410663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang W, &amp; Hu F (2021). Cellular and physiological functions of C9ORF72 and implications for ALS/FTD. Journal of neurochemistry, 157(3). 10.1111/jnc.15255</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15255</ArticleId><ArticleId IdType="pmc">PMC8842544</ArticleId><ArticleId IdType="pubmed">33259633</ArticleId></ArticleIdList></Reference><Reference><Citation>Panman JL, Jiskoot LC, Bouts M, Meeter LHH, van der Ende EL, Poos JM, &#x2026; Papma JM (2019). Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study. Neurobiol Aging, 76, 115&#x2013;124. 10.1016/j.neurobiolaging.2018.12.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.12.017</ArticleId><ArticleId IdType="pubmed">30711674</ArticleId></ArticleIdList></Reference><Reference><Citation>Papma JM, Jiskoot LC, Panman JL, Dopper EG, den Heijer T, Donker Kaat L, &#x2026; van Swieten JC (2017). Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology, 89(12), 1256&#x2013;1264. 10.1212/wnl.0000000000004393</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000004393</ArticleId><ArticleId IdType="pubmed">28855404</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins E, Burr K, Banerjee P, Mehta A, Dando O, Selvaraj B, &#x2026; Livesey M (2021). Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction. Molecular neurodegeneration, 16(1). 10.1186/s13024-021-00433-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00433-8</ArticleId><ArticleId IdType="pmc">PMC7931347</ArticleId><ArticleId IdType="pubmed">33663561</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, &amp; Grosskreutz J (2013). The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 14(7-8), 507&#x2013;515. 10.3109/21678421.2013.812661</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.812661</ArticleId><ArticleId IdType="pubmed">23889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, &#x2026; Petrucelli L (2015). Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci, 18(8), 1175&#x2013;1182. 10.1038/nn.4065</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Campoy O, Avila-Polo R, Grau-Rivera O, Antonell A, Clarimon J, Rojas-Garcia R, &#x2026; Gelpi E (2018). Systematic Screening of Ubiquitin/p62 Aggregates in Cerebellar Cortex Expands the Neuropathological Phenotype of the C9orf72 Expansion Mutation. J Neuropathol Exp Neurol, 77(8), 703&#x2013;709. 10.1093/jnen/nly047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nly047</ArticleId><ArticleId IdType="pubmed">29889265</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, &#x2026; Traynor BJ (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72(2), 257&#x2013;268. 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausbier M, Hu H, Arntz C, Feil S, Kamm S, Adelsberger H, &#x2026; Ruth P (2004). Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. Proc Natl Acad Sci U S A, 101(25), 9474&#x2013;9478. 10.1073/pnas.0401702101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0401702101</ArticleId><ArticleId IdType="pmc">PMC439001</ArticleId><ArticleId IdType="pubmed">15194823</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C, Campanari M, Julie Corbier C, Gaucherot A, Kolb-Cheynel I, Oulad-Abdelghani M, &#x2026; Charlet-Berguerand N (2016). Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. The EMBO journal, 35(12). 10.15252/embj.201593350</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q, Liang C, Chang Q, Zhang W, Yang M, &amp; Chen J (2019). C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta neuropathologica communications, 7(1). 10.1186/s40478-019-0685-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0685-7</ArticleId><ArticleId IdType="pmc">PMC6398253</ArticleId><ArticleId IdType="pubmed">30832726</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats K, Li Y, Chang W, Hung S, &#x2026; Ichida J (2018). Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nature medicine, 24(3). 10.1038/nm.4490</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadasan R, Hornburg D, Drepper C, Frank N, Jablonka S, Hansel A, &#x2026; Sendtner M (2016). C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nature neuroscience, 19(12). 10.1038/nn.4407</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4407</ArticleId><ArticleId IdType="pubmed">27723745</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F, Ioannides Z, van Eijk R, Heggie S, Thorpe K, Ceslis A, &#x2026; Ngo S (2018). Hypermetabolism in ALS is associated with greater functional decline and shorter survival. Journal of neurology, neurosurgery, and psychiatry, 89(10). 10.1136/jnnp-2017-317887</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudria-Lopez E, Koppers M, de Wit M, van der Meer C, Westeneng H, Zundel C, &#x2026; Pasterkamp R (2016). Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta neuropathologica, 132(1). 10.1007/s00401-016-1581-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1581-x</ArticleId><ArticleId IdType="pmc">PMC4911370</ArticleId><ArticleId IdType="pubmed">27206760</ArticleId></ArticleIdList></Reference><Reference><Citation>Swensen A, &amp; Bean B (2003). Ionic Mechanisms of Burst Firing in Dissociated Purkinje Neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience, 23(29). 10.1523/JNEUROSCI.23-29-09650.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-29-09650.2003</ArticleId><ArticleId IdType="pmc">PMC6740460</ArticleId><ArticleId IdType="pubmed">14573545</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W, &amp; Van Den Bosch L (2020). RNA toxicity in non-coding repeat expansion disorders. The EMBO journal, 39(1). 10.15252/embj.2018101112</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101112</ArticleId><ArticleId IdType="pmc">PMC6939197</ArticleId><ArticleId IdType="pubmed">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Devenney E, Dobson-Stone C, Kwok JB, Hodges JR, Kiernan MC, &#x2026; Hornberger M (2014). Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One, 9(8), e105632. 10.1371/journal.pone.0105632</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105632</ArticleId><ArticleId IdType="pmc">PMC4140802</ArticleId><ArticleId IdType="pubmed">25144223</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Rouleau G, Dion P, &amp; Parker J (2013). Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PloS one, 8(12). 10.1371/journal.pone.0083450</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083450</ArticleId><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, D'Alvano G, Bonavita S, &amp; Tedeschi G (2020). Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link? Int J Mol Sci, 21(10). 10.3390/ijms21103647</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103647</ArticleId><ArticleId IdType="pmc">PMC7279172</ArticleId><ArticleId IdType="pubmed">32455692</ArticleId></ArticleIdList></Reference><Reference><Citation>Trombetta-Lima M, Krabbendam IE, &amp; Dolga AM (2020). Calcium-activated potassium channels: implications for aging and age-related neurodegeneration. Int J Biochem Cell Biol, 123, 105748. 10.1016/j.biocel.2020.105748</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2020.105748</ArticleId><ArticleId IdType="pubmed">32353429</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, Leech JM, &#x2026; Sahin M (2012). Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature, 488(7413), 647&#x2013;651. 10.1038/nature11310</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11310</ArticleId><ArticleId IdType="pmc">PMC3615424</ArticleId><ArticleId IdType="pubmed">22763451</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, Gendron TF, Baker MC, DeJesus-Hernandez M, Finch NA, Brown PH, &#x2026; Rademakers R (2015). Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72. Acta Neuropathol, 130(6), 863&#x2013;876. 10.1007/s00401-015-1480-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1480-6</ArticleId><ArticleId IdType="pmc">PMC4655160</ArticleId><ArticleId IdType="pubmed">26437865</ArticleId></ArticleIdList></Reference><Reference><Citation>Voelkl B, Altman NS, Forsman A, Forstmeier W, Gurevitch J, Jaric I, &#x2026; W&#xfc;rbel H (2020). Reproducibility of animal research in light of biological variation. Nat Rev Neurosci, 21(7), 384&#x2013;393. 10.1038/s41583-020-0313-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-020-0313-3</ArticleId><ArticleId IdType="pubmed">32488205</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SS, Sandoe J, &#x2026; Woolf CJ (2014). Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep, 7(1), 1&#x2013;11. 10.1016/j.celrep.2014.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, Baumer D, East S, Neal J, Morris HR, Ansorge O, &amp; Blake DJ (2014). Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging, 35(7), 1779.e1775&#x2013;1779.e1713. 10.1016/j.neurobiolaging.2014.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Wang H, Carrera I, Xu S, &amp; Lakshmana M (2015). COPS5 protein overexpression increases amyloid plaque burden, decreases spinophilin-immunoreactive puncta, and exacerbates learning and memory deficits in the mouse brain. The Journal of biological chemistry, 290(14). 10.1074/jbc.M114.595926</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.595926</ArticleId><ArticleId IdType="pmc">PMC4423713</ArticleId><ArticleId IdType="pubmed">25713139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Liu H, Itoh K, Oh S, Zhao L, Murata D, &#x2026; Wang J (2021). C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab, 33(3), 531&#x2013;546.e539. 10.1016/j.cmet.2021.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC8579819</ArticleId><ArticleId IdType="pubmed">33545050</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Ou R, Cao B, Chen Y, Hou Y, Zhang L, &#x2026; Shang H (2021). Early weight instability is associated with cognitive decline and poor survival in amyotrophic lateral sclerosis. Brain research bulletin, 171. 10.1016/j.brainresbull.2021.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2021.02.022</ArticleId><ArticleId IdType="pubmed">33636227</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Fifita JA, Vucic S, Durnall JC, Kiernan MC, Blair IP, &amp; Nicholson GA (2013). Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry, 84(8), 931&#x2013;935. 10.1136/jnnp-2012-304529</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304529</ArticleId><ArticleId IdType="pubmed">23463871</ArticleId></ArticleIdList></Reference><Reference><Citation>Womack MD, Hoang C, &amp; Khodakhah K (2009). Large conductance calcium-activated potassium channels affect both spontaneous firing and intracellular calcium concentration in cerebellar Purkinje neurons. Neuroscience, 162(4), 989&#x2013;1000. 10.1016/j.neuroscience.2009.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.05.016</ArticleId><ArticleId IdType="pmc">PMC2723190</ArticleId><ArticleId IdType="pubmed">19446607</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooley C, Sher R, Kale A, Frankel W, Cox G, &amp; Seburn K (2005). Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle &amp; nerve, 32(1). 10.1002/mus.20228</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20228</ArticleId><ArticleId IdType="pmc">PMC1350398</ArticleId><ArticleId IdType="pubmed">15880561</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, MacNair L, McGoldrick P, McKeever PM, McLean JR, Zhang M, &#x2026; Robertson J (2015). Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann Neurol, 78(4), 568&#x2013;583. 10.1002/ana.24469</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24469</ArticleId><ArticleId IdType="pubmed">26174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh T, Liu H, Li Y, Lu C, Shih H, Chiu C, &#x2026; Cheng Y (2018). C9orf72 is essential for neurodevelopment and motility mediated by Cyclin G1. Experimental neurology, 304. 10.1016/j.expneurol.2018.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.03.002</ArticleId><ArticleId IdType="pubmed">29522758</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoi F, Dang MT, Li J, Standaert DG, &amp; Li Y (2011). Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice. PLoS One, 6(9), e24539. 10.1371/journal.pone.0024539</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024539</ArticleId><ArticleId IdType="pmc">PMC3171455</ArticleId><ArticleId IdType="pubmed">21931745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoi F, Oleas J, Xing H, Liu Y, Dexter KM, Misztal C, &#x2026; Li Y (2020). Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice. Neurobiol Dis, 134, 104638. 10.1016/j.nbd.2019.104638</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104638</ArticleId><ArticleId IdType="pmc">PMC7323754</ArticleId><ArticleId IdType="pubmed">31618684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoi F, Yang G, Li J, DeAndrade MP, Zhou T, &amp; Li Y (2010). Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce. J Biochem, 148(4), 459&#x2013;466. 10.1093/jb/mvq078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvq078</ArticleId><ArticleId IdType="pmc">PMC2981491</ArticleId><ArticleId IdType="pubmed">20627944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XM, Ng AH, Tanner JA, Wu WT, Copeland NG, Jenkins NA, &amp; Huang JD (2004). Highly restricted expression of Cre recombinase in cerebellar Purkinje cells. Genesis, 40(1), 45&#x2013;51. 10.1002/gene.20062</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gene.20062</ArticleId><ArticleId IdType="pubmed">15354293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Aryal DK, Olsen RH, Urban DJ, Swearingen A, Forbes S, &#x2026; Hochgeschwender U (2016). Cre-dependent DREADD (Designer Receptors Exclusively Activated by Designer Drugs) mice. Genesis, 54(8), 439&#x2013;446. 10.1002/dvg.22949</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvg.22949</ArticleId><ArticleId IdType="pmc">PMC4990490</ArticleId><ArticleId IdType="pubmed">27194399</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron T, McAlonis-Downes M, Jiang L, Taylor A, &#x2026; Cleveland D (2020). Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nature neuroscience, 23(5). 10.1038/s41593-020-0619-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, &#x2026; Ranum LP (2013). RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A, 110(51), E4968&#x2013;4977. 10.1073/pnas.1315438110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>